(19)
(11) EP 0 944 620 A1

(12)

(43) Date of publication:
29.09.1999 Bulletin 1999/39

(21) Application number: 97948238.0

(22) Date of filing: 21.11.1997
(51) International Patent Classification (IPC): 
A61K 31/ 4178( . )
A61P 9/ 00( . )
A61P 25/ 00( . )
A61P 27/ 16( . )
C07D 403/ 12( . )
A61P 1/ 00( . )
A61P 11/ 00( . )
A61P 27/ 02( . )
A61P 43/ 00( . )
(86) International application number:
PCT/US1997/020551
(87) International publication number:
WO 1998/023609 (04.06.1998 Gazette 1998/22)
(84) Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

(30) Priority: 25.11.1996 US 19960031740P

(71) Applicant: THE PROCTER & GAMBLE COMPANY
Cincinnati, Ohio 45202 (US)

(72) Inventors:
  • CUPPS, Thomas, Lee
    Oxford, OH 45056 (US)
  • BOGDAN, Sophie, Eva
    Maineville, OH 45039 (US)
  • HENRY, Raymond, Todd
    Pleasant Plain, OH 45162 (US)
  • SHELDON, Russell, James
    Fairfield, OH 45014 (US)
  • SEIBEL, William, Lee
    Hamilton, OH 45011 (US)
  • ARES, Jeffrey, Joseph
    Hamilton, OH 45011 (US)

(74) Representative: Clemo, Nicholas Graham, et al 
Procter & Gamble Technical Centres Limited Patent Department Lovett House Lovett Road
Staines, Middlesex TW18 3AZ
Staines, Middlesex TW18 3AZ (GB)

   


(54) 2-IMIDAZOLINYLAMINOINDAZOLE COMPOUNDS USEFUL AS ALPHA-2 ADRENOCEPTOR AGONISTS